CommercialCoverageMedium impact
Coronavirus (COVID-19) Information
CareFirst BlueCross BlueShield·Provider News
Effective date
Jun 2, 2020
We identified it
Jun 20, 2026
Summary
CareFirst will cover COVID-19 antibody/serology testing under the Families First Coronavirus Response Act, but only when ordered by authorized providers for medically necessary cases with high likelihood of impacting clinical decisions. The policy emphasizes limited clinical utility and provides guidance on appropriate use scenarios.
Action Required
Immediately: Billing team must ensure COVID-19 antibody tests are only billed when: 1) Test is on FDA Emergency Use Authorization (EUA) list, 2) Ordered by physician/NP/authorized provider, 3) Medically necessary with high likelihood of impacting clinical decisions, 4) Used for limited scenarios like diagnosis support 9-14 days after illness onset or multisystem inflammatory syndrome in children. Verify EUA status before billing to avoid claim denials.